Artificial intelligence in European medicines regulation

Philip A. A. Hines; Ralf Herold; Luis Pinheiro; Zaide Frias; Peter Arlett

doi:10.1038/d41573-022-00190-3

Artificial intelligence in European medicines regulation

Philip A. A. Hines^*, Ralf Herold, Luis Pinheiro, Zaide Frias, Peter Arlett

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

Artificial intelligence tools are increasingly being applied in the development and use of medicines. Here, we provide a regulatory perspective on such applications.

Original language	English
Pages (from-to)	81-82
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	22
Issue number	2
DOIs	https://doi.org/10.1038/d41573-022-00190-3
Publication status	Published - 1 Feb 2023

Access to Document

10.1038/d41573-022-00190-3

Cite this

@article{300b43b001c149aa969d45c63a1a466e,

title = "Artificial intelligence in European medicines regulation",

abstract = "Artificial intelligence tools are increasingly being applied in the development and use of medicines. Here, we provide a regulatory perspective on such applications.",

author = "Hines, {Philip A. A.} and Ralf Herold and Luis Pinheiro and Zaide Frias and Peter Arlett",

year = "2023",

month = feb,

day = "1",

doi = "10.1038/d41573-022-00190-3",

language = "English",

volume = "22",

pages = "81--82",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Artificial intelligence in European medicines regulation

AU - Hines, Philip A. A.

AU - Herold, Ralf

AU - Pinheiro, Luis

AU - Frias, Zaide

AU - Arlett, Peter

PY - 2023/2/1

Y1 - 2023/2/1

N2 - Artificial intelligence tools are increasingly being applied in the development and use of medicines. Here, we provide a regulatory perspective on such applications.

AB - Artificial intelligence tools are increasingly being applied in the development and use of medicines. Here, we provide a regulatory perspective on such applications.

U2 - 10.1038/d41573-022-00190-3

DO - 10.1038/d41573-022-00190-3

M3 - Editorial

C2 - 36411368

SN - 1474-1776

VL - 22

SP - 81

EP - 82

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 2

ER -